The spectrum of mutations in the NZBR lines is similar to that found in commonly used breast cancer cell lines, except that the EVI2B, LRP1B and PMS2 mutations have not been reported in breast cancer lines (Table 3). This evidence concerns the gene PMS2 and breast cancer.